Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

47 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Infective complications in bone marrow transplantation].
Conde E, Rabuñal MJ, Richard C, Tapia M, Baro J, Romón I, Iriondo A, Insunza A, Bureo E, Olalla I, et al. Conde E, et al. Among authors: insunza a. Sangre (Barc). 1995 Feb;40(1):25-37. Sangre (Barc). 1995. PMID: 7716667 Spanish. No abstract available.
Tandem transplants with different high-dose regimens improve the complete remission rates in multiple myeloma. Results of a Grupo Español de Síndromes Linfoproliferativos/Trasplante Autólogo de Médula Osea phase II trial.
Lahuerta JJ, Grande C, Martínez-Lopez J, De La Serna J, Toscano R, Ortiz MC, Larregla S, Conde E, Insunza A, Gonzalez-San Miguel JD, Bargay J, Cabrera R, García-Ruiz JC, Albó C, García-Alonso L, Solano F, Vivancos P, León A, San Miguel J; Grupo Español de Síndromes Linfoproliferativos/Trasplante Autólogo de Médula Osea. Lahuerta JJ, et al. Among authors: insunza a. Br J Haematol. 2003 Jan;120(2):296-303. doi: 10.1046/j.1365-2141.2003.04067.x. Br J Haematol. 2003. PMID: 12542490 Free article. Clinical Trial.
FLAGIDA-lite is an effective regimen for patients between 70 and 80 years with acute myeloid leukemia or refractory anemia with excess blasts-2 and is feasible as outpatient treatment.
Bermúdez A, Pérez-Vázquez G, Insunza A, Baro J, Colorado M, Conde E, Díez-Gallarreta Z, Gutiérrez ML, López-Duarte M, Olalla I, Sanroma P, Yañez L, Iriondo A, Richard C. Bermúdez A, et al. Among authors: insunza a. Am J Hematol. 2012 Jan;87(1):42-4. doi: 10.1002/ajh.22192. Epub 2011 Oct 20. Am J Hematol. 2012. PMID: 22015963 Free article.
Risk adapted high-dose and dose-dense therapies modulate the impact of biological classification in diffuse large B-cell lymphoma prognosis.
Montes-Moreno S, Batlle A, de Villambrosía SG, Sánchez-Espiridión B, Cereceda L, González-Barca E, Purroy N, Pardal E, Martín A, Grande C, Mazorra F, Insunza A, Quero C, Aguiar D, Cruz MA, Rueda A, Llanos M, Codina JG, Arroyo FR, Caballero D, Conde E, López A, Provencio M, Piris M. Montes-Moreno S, et al. Among authors: insunza a. Haematologica. 2014 Aug;99(8):e138-41. doi: 10.3324/haematol.2014.104976. Epub 2014 Apr 24. Haematologica. 2014. PMID: 24763400 Free PMC article. Clinical Trial. No abstract available.
Unexpected outbreak of Epstein-Barr virus post-transplantation lymphoproliferative disorder after hematopoietic stem cell transplantation conditioning with thymoglobulin.
Yáñez L, Bermúdez A, Insunza A, Romón I, Richard C. Yáñez L, et al. Among authors: insunza a. Biol Blood Marrow Transplant. 2014 Sep;20(9):1457-8. doi: 10.1016/j.bbmt.2014.06.012. Epub 2014 Jun 24. Biol Blood Marrow Transplant. 2014. PMID: 24972250 Free article. No abstract available.
47 results